Sheng Lin

Title: Innovations and Contributions of Inventor Sheng Lin

Introduction

Sheng Lin is a prominent inventor based in Beijing, China. He has made significant contributions to the field of therapeutic compounds, holding a total of 4 patents. His work focuses on developing innovative solutions for treating various medical conditions.

Latest Patents

One of Sheng Lin's latest patents is titled "Interleukin-13 binding cyclic oligopeptides and methods of use thereof." This patent relates to cyclic oligopeptides that bind to interleukin-13 (IL-13), which are therapeutically useful in treating or preventing IL-13-associated skin disorders. The patent also outlines methods for producing these IL-13-binding cyclic oligopeptides. Another notable patent is for "Pyrroloquinolin compounds and methods of using same." This patent provides pyrroloquinolin compounds that are therapeutic, particularly for treating cell proliferative disorders. It also includes compositions and therapeutic methods involving these compounds.

Career Highlights

Sheng Lin has worked with notable organizations such as Beijing Xiaomi Mobile Software Co., Ltd. and the Chinese Academy of Sciences. His experience in these institutions has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Sheng Lin has collaborated with esteemed colleagues, including Jiangong Shi and Jianjun Zhang. These collaborations have further enhanced his research and development efforts in the field of therapeutic compounds.

Conclusion

Sheng Lin's innovative work and patents reflect his dedication to advancing medical therapies. His contributions are significant in the realm of treating skin disorders and cell proliferative disorders.